Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mortality after multivessel revascularisation involving the proximal left anterior descending artery.
Ono M, Hara H, Gao C, Kawashima H, Wang R, O'Leary N, Wykrzykowska JJ, Piek JJ, Mack MJ, Holmes D, Morice MC, Head S, Kappetein AP, Noack T, Davierwala PM, Mohr FW, Garg S, Onuma Y, Serruys PW; SYNTAX Extended Survival Investigators. Ono M, et al. Among authors: piek jj. Heart. 2022 Oct 28;108(22):1784-1791. doi: 10.1136/heartjnl-2022-320934. Heart. 2022. PMID: 35732441 Free PMC article.
Safety of low dose heparin in elective coronary angioplasty.
Koch KT, Piek JJ, de Winter RJ, David GK, Mulder K, Tijssen JG, Lie KI. Koch KT, et al. Among authors: piek jj. Heart. 1997 Jun;77(6):517-22. doi: 10.1136/hrt.77.6.517. Heart. 1997. PMID: 9227294 Free PMC article.
Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplasty.
Albertal M, Regar E, Piek JJ, Van Langenhove G, Carlier SG, Thury A, Sianos G, Boersma E, de Bruyne B, di Mario C, Serruys PW; Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) Study Group. Albertal M, et al. Among authors: piek jj. Am Heart J. 2001 Jul;142(1):81-6. doi: 10.1067/mhj.2001.115590. Am Heart J. 2001. PMID: 11431661
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ; HEBE investigators. Hirsch A, et al. Among authors: piek jj. Am Heart J. 2006 Sep;152(3):434-41. doi: 10.1016/j.ahj.2006.02.007. Am Heart J. 2006. PMID: 16923409
684 results